These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 23177341)
1. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies]. Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341 [TBL] [Abstract][Full Text] [Related]
2. The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study. Liu G; Li Y; Hu P; Cheng D; Shi H Nucl Med Commun; 2015 Jul; 36(7):709-16. PubMed ID: 25757200 [TBL] [Abstract][Full Text] [Related]
3. Whole-body PET/CT studies with lowered ¹⁸F-FDG doses: the influence of body mass index in dose reduction. Sánchez-Jurado R; Devis M; Sanz R; Aguilar JE; del Puig Cózar M; Ferrer-Rebolleda J J Nucl Med Technol; 2014 Mar; 42(1):62-7. PubMed ID: 24503348 [TBL] [Abstract][Full Text] [Related]
4. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer. Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138 [TBL] [Abstract][Full Text] [Related]
5. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results. Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802 [TBL] [Abstract][Full Text] [Related]
6. Normal uptake of 18F-FDG in the testis: an assessment by PET/CT. Kitajima K; Nakamoto Y; Senda M; Onishi Y; Okizuka H; Sugimura K Ann Nucl Med; 2007 Sep; 21(7):405-10. PubMed ID: 17876554 [TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests. Ouyang L; Shi ZY; Lin ZG Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185 [TBL] [Abstract][Full Text] [Related]
8. Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI. Rakheja R; Chandarana H; DeMello L; Jackson K; Geppert C; Faul D; Glielmi C; Friedman KP AJR Am J Roentgenol; 2013 Nov; 201(5):1115-9. PubMed ID: 24147485 [TBL] [Abstract][Full Text] [Related]
9. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT. Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124 [TBL] [Abstract][Full Text] [Related]
10. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis. Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032 [TBL] [Abstract][Full Text] [Related]
11. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Abele JT; Fung CI Radiology; 2010 Mar; 254(3):917-24. PubMed ID: 20177102 [TBL] [Abstract][Full Text] [Related]
12. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT. Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887 [TBL] [Abstract][Full Text] [Related]
13. Comparison of lesion-to-cerebellum uptake ratios and standardized uptake values in the evaluation of lung nodules with 18F-FDG PET. Obrzut S; Pham RH; Vera DR; Badran K; Hoha CK Nucl Med Commun; 2007 Jan; 28(1):7-13. PubMed ID: 17159543 [TBL] [Abstract][Full Text] [Related]
14. Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). Bucci M; Aparici CM; Hawkins R; Bacharach S; Schrek C; Cheng S; Tong E; Arora S; Parati E; Wintermark M J Neuroimaging; 2014; 24(2):117-23. PubMed ID: 22928741 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Liao S; Penney BC; Zhang H; Suzuki K; Pu Y Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679 [TBL] [Abstract][Full Text] [Related]
16. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI. Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765 [TBL] [Abstract][Full Text] [Related]
17. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [TBL] [Abstract][Full Text] [Related]
18. PET/CT mediastinal and liver FDG uptake: effects of biological and procedural factors. Malladi A; Viner M; Jackson T; Mercier G; Subramaniam RM J Med Imaging Radiat Oncol; 2013 Apr; 57(2):169-75. PubMed ID: 23551774 [TBL] [Abstract][Full Text] [Related]
19. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI. Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT. Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]